Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-011432

Director sold 4,497 shares at an average $60.37 ($271,467)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Henderson Jeffrey William Director 2025-04-28 Sale 10b5-1 −4,297 $60.34 $259,268 28,811 D
Henderson Jeffrey William Director 2025-04-28 Sale 10b5-1 −200 $61.00 $12,199 28,611 D
Open-market sales · 4,497 sh · avg $60.37 · $271,467
Loading xslF345X05/form4-04282025_100414.xml…